AroCell AB (AROC):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:AroCell AB (AROC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9389
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AroCell AB (AroCell), formerly Xi Bao Research AB, is a drug development company that develops and commercializes tests used for the prognosis and monitoring of treatment of cancer. The company develops TK 210 ELISA kits for measuring the enzyme TK1 which is a protein that is elevated in the blood when there is increased cell turnover (cell growth and cell death) within the patient. Its TK 210 ELISA kits provide the tests for studying cellular proliferation, tumor cell turnover, and therapy response. AroCell is headquartered in Uppsala, Sweden.

AroCell AB (AROC) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AroCell AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AroCell AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AroCell AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AroCell AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
AroCell AB, Medical Devices Deals, 2012 to YTD 2018 9
AroCell AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
AroCell AB, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
AroCell Enters into Co-Development Agreement with Green Cross Cell 11
AroCell Enters Into Agreement With GenScript To Develop New Antibodies 12
Equity Offering 13
AroCell Completes Rights Offering Of Units For US$1.3 Million 13
AroCell AB – Key Competitors 14
AroCell AB – Key Employees 15
AroCell AB – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Financial Announcements 17
Mar 08, 2018: TG Therapeutics, Inc. Announces Fourth Quarter and Year-End 2017 Financial Results and Business Update 17
Nov 22, 2017: AroCell : Reporting period 1 July – 30 September 2017 19
Aug 24, 2017: AroCell: Interim report, Q2 2017 20
Feb 16, 2017: AroCell: (publ) Year-End Report 22
Corporate Communications 24
Aug 30, 2018: AroCell appoints Anders Hultman as its new CFO 24
Government and Public Interest 25
Aug 24, 2018: New publication from AroCell demonstrating the value of Thymidine Kinase 1 as a tumor biomarker 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
AroCell AB, Pharmaceuticals & Healthcare, Key Facts, 2017 2
AroCell AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AroCell AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AroCell AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AroCell AB, Deals By Therapy Area, 2012 to YTD 2018 8
AroCell AB, Medical Devices Deals, 2012 to YTD 2018 9
AroCell AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
AroCell Enters into Co-Development Agreement with Green Cross Cell 11
AroCell Enters Into Agreement With GenScript To Develop New Antibodies 12
AroCell Completes Rights Offering Of Units For US$1.3 Million 13
AroCell AB, Key Competitors 14
AroCell AB, Key Employees 15

List of Figures
AroCell AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
AroCell AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
AroCell AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
AroCell AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
AroCell AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AroCell AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
AroCell AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AroCell AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
AroCell AB, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[AroCell AB (AROC):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Diagnostics For All Inc:企業の製品パイプライン分析
    Summary Diagnostics For All Inc (DFA) is a drug development company that develops and commercializes of new technology and practical diagnostic devices for diagnostic companies. The company uses patterned paper technology to create electrochemical clinical chemistry assays, immunoassays, assays, and …
  • Zogenix Inc (ZGNX):企業の財務・戦略的SWOT分析
    Zogenix Inc (ZGNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • HTG Molecular Diagnostics Inc (HTGM):製薬・医療:M&Aディール及び事業提携情報
    Summary HTG Molecular Diagnostics Inc (HTG) is a technology company that provides molecular technology solutions. The company provides products such as HTG edge system, HTG edgeseq reagents and HTG edgeseq immuno-oncology biomarker panel assay, among others. It develops assays and reagent systems th …
  • NuVasive Inc (NUVA):医療機器:M&Aディール及び事業提携情報
    Summary NuVasive Inc (NuVasive) is a medical device company that provides minimally invasive, procedurally-integrated spine solutions. The company principally provides Maximum Access Surgery (MAS), a minimally-disruptive surgical platform. MAS platform enables surgeons to perform a range of minimall …
  • Oriental Yeast Co Ltd:企業の戦略・SWOT・財務情報
    Oriental Yeast Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Oriental Yeast Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • China Minsheng Banking Corp Ltd:企業の戦略・SWOT・財務情報
    China Minsheng Banking Corp Ltd - Strategy, SWOT and Corporate Finance Report Summary China Minsheng Banking Corp Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Diageo plc:企業の戦略・SWOT・財務情報
    Diageo plc - Strategy, SWOT and Corporate Finance Report Summary Diageo plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • New York Power Authority:戦略・SWOT・企業財務分析
    New York Power Authority - Strategy, SWOT and Corporate Finance Report Summary New York Power Authority - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Chesswood Group Ltd (CHW):企業の財務・戦略的SWOT分析
    Chesswood Group Ltd (CHW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Al Hassan Engineering Co (HECI):企業の財務・戦略的SWOT分析
    Al Hassan Engineering Co (HECI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Intuitive Surgical Inc (ISRG)-医療機器分野:企業M&A・提携分析
    Summary Intuitive Surgical Inc (Intuitive Surgical) is a provider of robotic-assisted minimally invasive surgery (MIS) devices. Its portfolio encompasses da Vinci Surgical Systems, InSite and Firefly Fluorescence imaging systems (Firefly), instruments and accessories and training technologies. The c …
  • Polyplex (Thailand) Public Company Limited:企業の戦略・SWOT・財務分析
    Polyplex (Thailand) Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Polyplex (Thailand) Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Zeus Co., Ltd. (079370):企業の財務・戦略的SWOT分析
    Zeus Co., Ltd. (079370) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Cytox Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Cytox Ltd (Cytox) is a diagnostic and prognostic service provider that develops services for neurodegenerative disorders. The company’s blood tests are used to predict, which patients with MCI will develop Alzheimer's disease. Its biomarkers are based on the cell cycle hypothesis of Alzheime …
  • Punjab National Bank (PNB):電力:M&Aディール及び事業提携情報
    Summary Punjab National Bank (PNB) offers retail and commercial banking, agricultural and international banking, and other financial services. Its retail and commercial banking portfolio offers credit and debit cards, corporate and retail loans, deposit services, cash management, and export and impo …
  • The Nature’s Bounty Co:企業の戦略的SWOT分析
    The Nature's Bounty Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Hoegh LNG Holdings Ltd (HLNG):石油・ガス:M&Aディール及び事業提携情報
    Summary Hoegh LNG Holdings Ltd (Hoegh LNG), formerly Leif Hoegh & Co Ltd is an oil and gas company that offers oilfield services and floating energy solutions. The company's services include floating storage and regasification unit solutions, in-house ship management, floating LNG energy services, L …
  • Neiman Marcus Group LTD LLC:企業の戦略的SWOT分析
    Neiman Marcus Group LTD LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • IMV Inc (IMV):企業の財務・戦略的SWOT分析
    Summary IMV Inc (IMV), formerly Immunovaccine Inc, is a biopharmaceutical company that develops immunotherapies and vaccines to treat cancer and infectious diseases. The company is investigating its pipeline candidates DPX-Survivac against ovarian, bladder, liver, non-small cell lung cancer and diff …
  • National Surgical Hospitals Inc-製薬・医療分野:企業M&A・提携分析
    Summary National Surgical Hospitals Inc (NSH) is a healthcare organization that owns, operates and manages surgical facilities. The organization’s management services include operational, clinical, information services, managed care services, legal and compliance services, human resource services, s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆